Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice

Gerodontology

Volumn 18, Issue 1, 2001, Pages 21-24

  Field, E A ^a   Fear, S ^b   Higham, S M ^a   Ireland, R S ^a   Rostron, J ^a   Willetts, R M ^c   Longman, L P ^a  

^a LIVERPOOL UNIVERSITY DENTAL HOSPITAL   (United Kingdom)

^b Roy Castle International Centre for Lung Cancer Research   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTICE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS; UNITED KINGDOM; XEROSTOMIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; GENERAL PRACTICE, DENTAL; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHARMACEUTICAL PREPARATIONS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; STATISTICS; XEROSTOMIA;

EID: 0035411959     PISSN: 07340664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1741-2358.2001.00021.x     Document Type: Article

References (14)

1. 1 Fox PC, Busch K A, Baum B J. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987 ; 115: 581–584.
2. 2 Field E A, Longman L P, Higham S M, et al. The establishment of a xerostomia clinic; a prospective study. Br Maxillofacial Surg 1997 ; 35: 96–103.
3. 3 Longman L P, McCracken C F M, Higham S M, et al. The clinical assessment of oral dryness is a significant predictor of salivary gland hypofunction. Oral Diseases 2000 ; 6: 366–370.
4. 4 Sreebny L M, Banoczy J, Baum B J, et al. Saliva: Its role in health and disease. Int Dent J 1992 ; 42 (Suppl 2): 291–304.
5. 5 Sreebny LM. Saliva: In Health and Disease ‐ an appraisal and update. Int Dent J 50: 140–161.
6. 6 Locker D. Xerostomia in older adults: a longitudinal study. Gerodontology 1995 ; 12: 18–25.
7. 7 Narhi T O, Meurman J H, Ainamo A, et al. Association between salivary flow rate and the use of systemic medication among 76–81, and 86‐year‐old inhabitants in Helsinki, Finland. J Dent Res 1992 ; 71: 1875–1880.
8. 8 Hochberg M C, Tielsch J, Munoz B, et al. Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: the SEE project. Salisbury Eye Evaluation. J Rheumatol 1998 ; 25 (3): 486–491.
9. 9 Sreebny L M, Valdini A. Xerostomia, Part I: Relationship to other symptoms and salivary gland hypofunction, Oral Surg Oral Med Oral Pathol 1988 ; 66: 451–458.
10. 10 Billings R J, Proskin H M, Moss M E. Xerostomia and associated factors in a community‐dwelling adult population. Community Dent Oral Epidemiol 1996 ; 24: 312–316.
11. 11 Nederfors T, Isaksson R, Mornstad H, et al. Prevalence of perceived symptoms of dry mouth in an adult Swedish population ‐ relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 1997 ; 25: 211–216.
12. 12 Vitali C, Bombardieri S, Moutsopoules H M, et al. Preliminary criteria for the classification of Sjogren's Syndrome. Arthritis Rheum 1993 ; 36: 340–347.
13. 13 Bergdahl M. Salivary flow and oral complaints in adult dental patients. Community Dent Oral Epidemiol 2000 ; 28: 59–66.
14. 14 Sreebny L M, Schwartz S. Reference guide o t drugs and dry mouth. Gerodontology 1986 ; 5: 75–99.